| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/29/2012 | CA2441597C Elongated and multiple spacers in activatible prodrugs |
| 05/29/2012 | CA2440767C Novel neurotrophic factors |
| 05/29/2012 | CA2432416C Method of creating biological and biosynthetic material for implantation |
| 05/29/2012 | CA2403985C Angiogenic onchocerca volvulus proteins and uses thereof |
| 05/29/2012 | CA2403817C Methods of modulating hair growth |
| 05/29/2012 | CA2403327C Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 05/29/2012 | CA2395053C Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/29/2012 | CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 05/29/2012 | CA2379388C Immunoglobulin fusion proteins |
| 05/29/2012 | CA2377957C Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 05/29/2012 | CA2361292C A novel chimeric protein for prevention and treatment of hiv infection |
| 05/29/2012 | CA2343579C Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/29/2012 | CA2341340C Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| 05/29/2012 | CA2338005C Peptide antagonists of zonulin and methods for use of the same |
| 05/29/2012 | CA2329148C Specific binding proteins for treating canine allergy |
| 05/29/2012 | CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 05/29/2012 | CA2280736C Methods for modulating hematopoiesis and vascular growth |
| 05/29/2012 | CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use |
| 05/29/2012 | CA2220777C Novel heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists |
| 05/24/2012 | WO2012068553A2 Methods of diagnosing and treating neurodegenerative diseases |
| 05/24/2012 | WO2012068477A1 Methods and compositions for inhibiting angiogenesis and tumor growth |
| 05/24/2012 | WO2012068464A2 Methods of treating and preventing thrombotic diseases using ask1 inhibitors |
| 05/24/2012 | WO2012068376A2 Keratin compositions for treatment of bone deficiency or injury |
| 05/24/2012 | WO2012068355A2 Treating aortic aneurysm by modulating toll-like receptors |
| 05/24/2012 | WO2012068341A2 Wnt1 for treatment of cardiovascular disorders and injuries |
| 05/24/2012 | WO2012068282A1 Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 05/24/2012 | WO2012068236A2 Novel fungal oxidoreductases |
| 05/24/2012 | WO2012068032A1 Fgfr1 extracellular domain combination therapies |
| 05/24/2012 | WO2012068030A1 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins |
| 05/24/2012 | WO2012067866A2 Multivalent vaccine for filariasis |
| 05/24/2012 | WO2012067621A1 Preparation and use of combination enzyme and gastrointestinal modulator delivery systems |
| 05/24/2012 | WO2012067427A2 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration |
| 05/24/2012 | WO2012067262A1 Therapeutic agent for muscular dystrophy |
| 05/24/2012 | WO2012066086A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SULFOBUTYL ETHER 7-ß-CYCLODEXTRIN |
| 05/24/2012 | WO2012066036A1 A PROCESS FOR REDUCTION AND/OR REMOVAL OF FXI AND FXIa FROM SOLUTIONS CONTAINING SAID COAGULATION FACTORS |
| 05/24/2012 | WO2012065996A1 PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND MALTOSYL-ß-CYCLODEXTRIN |
| 05/24/2012 | WO2012065651A1 A synergistic composition of plant extracts for treating skin diseases involving abnormal cell growth |
| 05/24/2012 | WO2012065362A1 Myomegalin variant 8 and uses thereof |
| 05/24/2012 | WO2012065248A1 Method for increasing neprilysin expression and activity |
| 05/24/2012 | WO2012065212A1 Anti-inflammatory compositions |
| 05/24/2012 | WO2012065201A1 Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 05/24/2012 | WO2012046006A3 Cutaneous squamous cell carcinoma target sequences |
| 05/24/2012 | WO2012037043A8 Treatment of autoimmune inflammation using mir-155 |
| 05/24/2012 | WO2012026712A3 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof |
| 05/24/2012 | WO2012024309A3 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
| 05/24/2012 | WO2012023838A3 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
| 05/24/2012 | WO2012016162A3 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| 05/24/2012 | WO2012015681A3 Drug-ligand conjugates, synthesis thereof, and intermediates thereto |
| 05/24/2012 | WO2012015211A3 Opthalmic formulation containing cyclosporine a |
| 05/24/2012 | WO2012008779A3 A liquid formulation of long-acting human growth hormone conjugate |
| 05/24/2012 | WO2012006497A3 Mu opioid receptor agonist analogs of the endomorphins |
| 05/24/2012 | WO2012006101A3 Blood substitutes and uses thereof |
| 05/24/2012 | WO2012003281A3 Small-molecule-targeted protein degradation |
| 05/24/2012 | WO2011163539A3 nAChRα7 AGONISTS AND nAChRα7 ANTAGONISTS FOR TREATING ULCERATIVE COLITIS (UC) AND CROHN'S DISEASE (CD) |
| 05/24/2012 | WO2011161217A3 Targeting of vegfr2 |
| 05/24/2012 | WO2011153277A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 05/24/2012 | WO2011152618A3 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof |
| 05/24/2012 | WO2011150284A3 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 05/24/2012 | WO2011098999A3 Chemical preparation of ubiquitin thioesters and modifications thereof |
| 05/24/2012 | WO2011086093A3 Pharmaceutical compositions for oral administration of insulin peptides |
| 05/24/2012 | WO2010033254A8 Process for the synthesis of (aib8,35)hglp-1(7-36)-nh2 |
| 05/24/2012 | US20120130435 Compositions and methods for arthrodetic procedures |
| 05/24/2012 | US20120130300 Therapeutic Methods Using Controlled Delivery Devices Having Zero Order Kinetics |
| 05/24/2012 | US20120130146 Continuous administration of cilengitide in cancer treatments |
| 05/24/2012 | US20120130144 Treatment of lung cancer with a nitrobenzamide compound in combination with a growth factor inhibitor |
| 05/24/2012 | US20120130046 Tropoelastin derivatives |
| 05/24/2012 | US20120130044 Stable Analogs of Peptide and Polypeptide Therapeutics |
| 05/24/2012 | US20120129792 Agent for eliminating multidrug resistance |
| 05/24/2012 | US20120129791 Stimulator of genital, sexual and reproductive function |
| 05/24/2012 | US20120129790 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 05/24/2012 | US20120129789 Compositions and methods for hair growth |
| 05/24/2012 | US20120129788 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer |
| 05/24/2012 | US20120129787 Modified oligopeptides with anticancer properties and methods of obtaining them |
| 05/24/2012 | US20120129785 Companion animal nutrition system |
| 05/24/2012 | US20120129784 Oligopeptides And Cosmetic Compositions Containing The Oligopeptides |
| 05/24/2012 | US20120129783 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| 05/24/2012 | US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders |
| 05/24/2012 | US20120129781 Composition comprising alpha-lipoic acid and carnosine for treating the phantom limb syndrome |
| 05/24/2012 | US20120129780 Lactoferrin and brain health and protection in adults |
| 05/24/2012 | US20120129779 Tubulysine derivatives |
| 05/24/2012 | US20120129778 Ligand that bind tgf-beta receptor rii |
| 05/24/2012 | US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides |
| 05/24/2012 | US20120129776 Bioactive peptides and method of using same |
| 05/24/2012 | US20120129775 Antiangiogenic small molecules and methods of use |
| 05/24/2012 | US20120129774 Kinin b1 receptor peptide agonists and uses thereof |
| 05/24/2012 | US20120129773 Methods of treating autism and autism spectrum disorders |
| 05/24/2012 | US20120129772 Soluble igf receptors as anti-angiogenic agents |
| 05/24/2012 | US20120129771 Peptides and related molecules that modulate nerve growth factor activity |
| 05/24/2012 | US20120129770 Novel polynucleotide molecules for enhanced gene expression |
| 05/24/2012 | US20120129769 Orally administerable pharmaceutical preparation containing insulin |
| 05/24/2012 | US20120129768 Glp-1 analogues and their pharmaceutical salts and uses |
| 05/24/2012 | US20120129767 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment |
| 05/24/2012 | US20120129766 Methods of treating fgf21-associated disorders |
| 05/24/2012 | US20120129765 Novel specific hcv ns3 protease inhibitors |
| 05/24/2012 | US20120129764 Influenza a and b virus replication-inhibiting peptides |
| 05/24/2012 | US20120129763 Novel semi-synthetic glycopeptides as antibacterial agents |
| 05/24/2012 | US20120129762 Motilin-like peptide compound having transmucosal absorbability imparted thereto |
| 05/24/2012 | US20120129761 Preparation of bone cement compositions |
| 05/24/2012 | US20120129760 Modified peptides with antiviral properties and methods for obtaining them |
| 05/24/2012 | US20120129759 Protein surface remodeling |